At the time of writing, Alkermes plc [ALKS] stock is trading at $31.22, up 1.96%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ALKS shares have gain 5.47% over the last week, with a monthly amount glided 10.83%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Alkermes plc [NASDAQ: ALKS] stock has seen the most recent analyst activity on November 11, 2025, when Truist initiated its Buy rating and assigned the stock a price target of $50. Previously, RBC Capital Mkts upgraded its rating to Outperform on September 26, 2025, and kept the price target unchanged to $44. On September 03, 2025, Wells Fargo initiated with a Overweight rating and assigned a price target of $44 on the stock. Goldman started tracking the stock assigning a Buy rating and suggested a price target of $43 on July 15, 2025. UBS upgraded its rating to a Buy but $42 remained the price target by the analyst firm on June 17, 2025. Needham started tracking with a Buy rating for this stock on May 28, 2025, and assigned it a price target of $45. In a note dated March 13, 2025, RBC Capital Mkts initiated an Sector Perform rating and provided a target price of $40 on this stock.
For the past year, the stock price of Alkermes plc fluctuated between $25.17 and $36.45. Currently, Wall Street analysts expect the stock to reach $46.57 within the next 12 months. Alkermes plc [NASDAQ: ALKS] shares were valued at $31.22 at the most recent close of the market. An investor can expect a potential return of 49.17% based on the average ALKS price forecast.
Analyzing the ALKS fundamentals
According to Alkermes plc [NASDAQ:ALKS], the company’s sales were 1.52B for trailing twelve months, which represents an 4.24% jump. Gross Profit Margin for this corporation currently stands at 0.86% with Operating Profit Margin at 0.24%, Pretax Profit Margin comes in at 0.26%, and Net Profit Margin reading is 0.22%. To continue investigating profitability, this company’s Return on Assets is posted at 0.15, Equity is 0.21 and Total Capital is 0.19. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Alkermes plc [NASDAQ:ALKS] has a current ratio of 3.67. As well, the Quick Ratio is 3.27, while the Cash Ratio is 1.3. Considering the valuation of this stock, the price to sales ratio is 3.39, the price to book ratio is 2.97 and price to earnings (TTM) ratio is 15.45.
Transactions by insiders
Recent insider trading involved Hopkinson Craig C., Officer, that happened on Jan 08 ’26 when 5000.0 shares were purchased. EVP R&D, Chief Medical Officer, Hopkinson Craig C. completed a deal on Jan 08 ’26 to sell 5000.0 shares. Meanwhile, EVP R&D, Chief Medical Officer Hopkinson Craig C. sold 4000.0 shares on Jan 02 ’26.
